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ABSTRACT
Motivation: With  the  continued  improvement  of  requisite  mass  spectrometers  and  UHPLC  systems, 
Hydrogen/Deuterium  eXchange  Mass  Spectrometry  (HDX-MS)  workflows  are  rapidly  evolving  towards  the 
investigation of more challenging biological systems, including large protein complexes and membrane proteins. The 
analysis  of  such  extensive  systems  results  in  very large  HDX-MS datasets  for  which specific  analysis  tools  are 
required to speed up data validation and interpretation. 
Results: We introduce a web application and a new R-package named “MEMHDX” to help users analyze, validate  
and  visualize  large  HDX-MS datasets.  MEMHDX  is  composed  of  two  elements.  A  statistical  tool  aids  in  the  
validation of the results by applying a mixed-effects model for each peptide, in each experimental condition, and at  
each time point, taking into account the time dependency of the HDX reaction and number of independent replicates.  
Two adjusted p-values are generated per peptide, one for the “Change in dynamics” and one for the “Magnitude of 
∆D”, and are used to classify the data by means of a “Logit” representation. A user-friendly interface developed with 
Shiny by RStudio facilitates the use of the package. This interactive tool allows the user to easily and rapidly validate,  
visualize and compare the relative deuterium incorporation on the amino acid sequence and 3D structure, providing  
both spatial and temporal information. 
Availability: MEMHDX is freely available as a web tool at the project home page http://memhdx.c3bi.pasteur.fr
Contact: marie-agnes.dillies@pasteur.fr; sebastien.brier@pasteur.fr
Supplementary information: Supplementary data is available at Bioinformatics online.
1. INTRODUCTION 
Hydrogen  Deuterium  eXchange  followed  by  Mass 
Spectrometry (HDX-MS) is a biophysical tool in structural 
biology  capable  of  probing  protein/ligand  interactions, 
conformational changes, and protein folding and dynamics . 
Despite an increased number of applications , the expansion 
of the technology has been slowed by its intrinsic technical 
and analytical complexity (i.e., digestion at pH 2.5 and rapid 
HPLC  separation  at  0°C).  With  recent  advancements  in 
sample  preparation  robotics,  refrigerated  ultra-high 
performance  liquid  chromatography  systems   and  high 
resolution  mass  spectrometers,  HDX-MS  has  surged  in 
popularity and is now emerging from the academic benchtop 
to the expanse of the pharmaceutical sector . 
The use of improved HDX-MS workflows enables the 
structural analysis of larger protein systems such as antigen-
antibody  complexes  (>  180  kDa)  or  integral  membrane 
proteins,  in  a  more  routine  way .  The characterization  of 
such systems results in very complex HDX-MS datasets, for 
which  specific  non-commercial  analytical  software  (e.g., 
HXExpress, HeXicon, ExMS, HDXFinder,  etc.), as well as 
commercial  platforms  (e.g.,  DynamX  and  HDExaminer), 
have  been  developed  .  Such  software  extract  deuterium 
incorporation information from (un)processed raw m/z data 
files and produce deuterium uptake curves that can pinpoint 
regions of interest on protein 3D structures. However, many 
of these tools do not integrate statistical approaches and use 
the absolute difference of deuterium uptake to evaluate the 
significance between conditions. 
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Hydra (or Mass Spec Studio) was the first standalone 
application to  introduce a Student’s  t-test  and  p-values  to 
statistically  evaluate  the  difference  across  HDX-MS 
experiments  .  Alternatively,  Houde  and  co-workers 
calculated  confidence  limits  based  on  the  experimental 
uncertainty  of  measuring  deuterium  uptake  across 
replicates  .  In  this  context,  two distinct  confidence  limits 
were  calculated  manually  using  either  the  differences  of 
deuterium uptake, or the summed value of HDX differences 
measured for each peptide,  in each condition, and at each 
time point. Lastly, HDX Workbench includes a two-tailed t-
test  and  Tukey  multiple  comparison  procedure  for  the 
statistical cross-comparison of two or more datasets .
Despite significant efforts to design requisite statistical 
tools, the aforementioned software solutions are suitable to 
analyze  HDX-MS data  at  one  time  point  only,  failing  to 
account for the time-dependency of the HDX-MS reaction. 
Thus, Liu and coworkers proposed a multiple regression or 
ANCOVA model . By deriving a statistical test based on the 
model parameters, they evaluated the significant difference 
between two groups under comparison, for all peptides in 
the dataset, and across all independent replicates. 
Expanding  on  this,  we  introduce  a  web  application 
named  “MEMHDX”  (Mixed-Effects  Model  for  HDX 
experiments)  to  aid  in  the  rapid  statistical  validation  and 
visualization of large HDX-MS datasets. MEMHDX uses a 
linear mixed-effects model where replicates are considered 
as  random  effects.  This  accounts  for  both  the  time 
dependency and the variability across replicates. Moreover, 
instead of testing the variation in global deuterium exchange 
between  two  experimental  conditions,  we  propose  to 
calculate two individual  p-values for each peptide. Firstly, 
the difference between conditions is measured (p-value for 
the “Magnitude of  Delta Deuterium (∆D)”), followed by the 
evolution of  the deuterium uptake behavior  over  the time 
course  of  the  experiment  (p-value  for  the  “Change  in 
dynamics”).  MEMHDX therefore  allows  the clustering of 
each peptide in the dataset based on these two respective p-
values.  A user-friendly interface developed with Shiny by 
RStudio facilitates the use of the application, allowing the 
user to easily visualize and compare the relative deuterium 
incorporation  across  the  entire  protein  sequence  and  3D 
structure.  As  a  test  system,  we  used  the  receptor-binding 
Repeat-in-ToXin  (RTX)  domain  of  CyaA  produced  by 
Bordetella  pertussis,  the  causative  agent  of  whooping 
cough,  to  pinpoint  regions  undergoing  structural  and 
conformational changes upon calcium binding .
2. METHODS
The description of the MEMHDX workflow is reported in 
Figure  1.  MEMHDX  is  composed  of  two  independent 
elements: a statistical tool written in R for the validation of 
HDX results,  and  a  web  interface  developed  with  Shiny. 
Details of the mixed-effects model, the Shiny web interface 
and the outputs are given below.
2.1. The MEMHDX R-package
2.1.1. The mixed-effects model 
The aim was to compare the exchange behavior of a defined 
set of  N peptides derived from the same protein placed in 
two distinct  states.  The  incorporation  was  measured  at  T 
time  points  (t1,…,tT)  for  all  peptides  in  both  biological 
conditions, and the experiment was repeated  R times.  Ya,i,r,t 
corresponds to the deuterium incorporation value measured 
for  peptide   ( ),  at  each  time  point   (
),  for  each  replicate   ( )  and 
condition  ( ), and can be calculated using:
,
,
,
where M and M0 correspond to the mass of the labeled and 
unlabeled peptide,  c represents the extracted centroid value 
(m/z),  and  z the  peptide  charge.  Thus,  we  consider  the 
following linear mixed-effects model:
where  is the vector of observations , βt,  βi 
and  βti correspond  to  the  vectors  of  fixed  effects  for  the 
time,  the  condition  and  the  interaction  between  time  and 
condition,   the vector of random effects (i.e., replicates), 
and  the vector of random errors. In our model, the time t, 
the  condition  i,  and  the  interaction  between  t and  i  are 
considered  as  fixed  effects.  The  condition  and  the 
interaction  represent  the  two  parameters  of  interest.  The 
replicates are considered as a random effect. 
2.1.2. The statistical inference 
The “nmle” R package was utilized to estimate the vectors 
of  fixed  effects  (β)  and  ur  (http://CRAN.R-
project.org/package=nlme).  The  restricted  maximum 
likelihood method was used to fit  the linear mixed-effects 
model. To evaluate the statistical significance of the 
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Fig. 1. The MEMHDX strategy. A .csv file containing deuterium uptake values for all identified peptides is exported after raw data extraction and analysis by  
dedicated HDX-MS software (e.g., DynamX). The .csv file is uploaded to MEMHDX where a linear mixed-effects model is applied to statistically validate the 
dataset. Main results are displayed on a “Logit” representation (for data clustering and validation) and visualized using a global summary plot and the 3D structure,  
where available. A user-friendly ShinyInterface facilitates the use of the application.
condition  and  the  interaction  on  the  rate  of  deuterium 
incorporation of the protein, two  p-values were calculated 
per peptide, using two individual Wald tests. The condition-
associated  p-value  (hereafter  referred  to  as  p-
valueMagnitude_of_Delta_D) tests the null hypothesis of there being 
no difference in deuterium uptake between condition 1 and 
2; the interaction-associated p-value (hereafter referred to as 
p-valueChange_in_dynamics) tests the null hypothesis of there being 
no  change  in  the  deuterium  uptake  behavior  between 
condition  1  and  2  and  takes  into  account  the  time 
dependency  of  the  HDX  reaction  (see  Comment  1  of 
Supplementary Material). A multiple testing procedure was 
applied to adjust the significance level of each Wald test. In 
this  work,  the  False  Discovery  Rate  (FDR)  criterion  was 
used instead of the classical familywise error rate to achieve 
higher statistical power . 
2.2. User interface and data output
2.2.1. The “Start analysis” window 
To facilitate the use of the MEMHDX R-package, a user-
friendly interactive web interface was developed with Shiny 
by RStudio (http://shiny.rstudio.com). The “Start analysis” 
window  (Supplementary  Figure  1A)  contains  a  short 
reminder of the main variables required in the input .csv file, 
i.e., the sequence and position of each peptide in the protein, 
charge state  z, extracted centroid  m/z values for each time 
point  and  replicate  and  in  each  condition,  exposure  time 
(min), number of replicates,  and the maximum number of 
exchangeable amide hydrogens (MaxUptake) that could be 
theoretically  replaced  into  the  peptide.  MaxUptake 
corresponds to the number of amino acid residues contained 
in  the peptide,  minus the number  of  proline residues  and 
minus  one  for  the  N-terminus  that  back-exchanges  too 
rapidly to be measured . Once the .csv file is loaded,  the 
system informs the user of any missing variables. Missing 
centroid m/z values are allowed; in such a scenario, they are 
automatically  replaced  by  the  mean  value  across  all 
replicates. 
Before  starting  any  analysis,  two  user-defined 
parameters must be defined: the statistical significance value 
(%) corresponding to the desired stringency of the analysis, 
and the percentage of deuterium (D) contained in the final 
labeling solution (Supplementary Figure 1A). The latter is 
used  to  calculate  the  Relative  Fractional  Uptake  (RFU) 
values. MEMHDX automatically generates RFU values as 
follows:
where  Ya,i,r,t corresponds  to  the  deuterium  incorporation 
value measured for peptide  at each time point t. RFU can 
be viewed as normalized deuterium uptake values (i.e., the 
number of incorporated deuterium becomes independent of 
the length of the peptide)  and are utilized to generate the 
global visualization charts.
2.2.2. Data output 
Once processing is complete, the “HDX-MS Results” panel 
appears  below  the  “Start  analysis”  window.  This  is 
composed  of  six  independent  tabs,  namely  Raw  Data, 
Peptide Plot, Logit Plot, Global Visualization, 3D Structure 
and Summary.
The “Raw Data” tab lists all the variables included in the 
.csv  file.  The  “Peptide  Plot”  tab  (Supplementary  Figure 
1B1)  allows  the  user  to  control  the  quality  of  the  fitted 
model for each peptide and to evaluate the reproducibility 
across replicates. The “Logit Plot” tab summarizes the main 
statistical  results  (Supplementary  Figure  1B2).  This  is 
divided  into  three  sections.  The  “plot  options”  section  is 
used  to  adjust  the  options  of  the  plot  (size  points,  max 
distance in pixels) and the export. The center area displays 
the “Logit”  representation,  where  each  dot represents  one 
individual peptide. The Logit  function of the two  p-values 
defines the position of each peptide in the graph. The red 
lines correspond to the statistical significance threshold for 
the “Magnitude of ∆D” (vertical line), and for the “Change 
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in  dynamics”  (horizontal  line),  thus  dividing  the  “Logit” 
Plot into four regions (Supplementary Figure 1B2): peptides 
only statistically significant for the “Change in dynamics” or 
the  “Magnitude  of  ∆D”  are  located  in  the  “a”  and  “b” 
region, respectively; statistically significant peptides in both 
states  are  clustered  in  the  “c”  region;  statistically  non-
significant  peptides  are  displayed  in  the  “d”  region.  The 
“Logit” viewing mode of MEMHDX provides a rapid and 
effective  way to discriminate  statistically  significant  from 
non-significant peptides and to classify each based on their 
respective HDX behavior. The final section appears at the 
bottom of the “Logit” screen after selection of an individual 
peptide  in  the  “Logit”  representation  (not  shown). 
MEMHDX  automatically  displays  a  summary  table 
containing the mean incorporation (in Da) per time point, 
and  state,  and  associated  “Logit”  values.  This  summary 
table can be exported into a .csv format. The identity of each 
peptide  (i.e.,  sequence,  position  and  deuterium  uptake 
curves)  appears  below  the  “Logit”  plot  when  the  mouse 
cursor is hovered over a dot. 
The “Global Visualization” and the “3D Structure” tabs 
are  dedicated  to  the  visualization  of  the  HDX  data  and 
contain  two  sections  (Supplementary  Figures  1B3,  1B4). 
The  left  section  allows  the  user  to  navigate  through  the 
different parameter options. The right section of the “Global 
Visualization”  summarizes  the  deuterium uptake  behavior 
observed  in  the  two  states  (Supplementary  Figure  1B3, 
upper  and  middle  charts).  The  RFU values  calculated  by 
MEMHDX are plotted as a function of peptide position. In 
addition,  the  lower  chart  plots  the  difference  in  RFU 
between  state  1  and  2,  providing  a  more  quantitative 
assessment  of  the  difference  between  states.  Statistically 
significant  peptides  are  highlighted  in  gray.  The  right 
section of the “3D Structure” tab displays the mapping of 
the  HDX  results  on  the  crystal  structure  of  the  protein 
(Supplementary  Figure  1B4).  Finally,  the  “Summary”  tab 
recaps  the  different  parameters  used  by  MEMHDX  to 
perform the statistical analysis and includes an export option 
for both the raw data and statistically relevant results (not 
shown).
3. RESULTS AND DISCUSSION
MEMHDX  was  developed  to  complement  the  HDX-MS 
pipeline  commercialized  by  Waters  Corporation.  The 
software is fully compatible with the main output generated 
by DynamX (i.e., cluster  data),  but  has  been  designed  to 
handle  data  from any  HDX-MS platform,  as  long  as  the 
input  file  is  structured  in  .csv  format  and  with  the 
appropriate  architecture,  i.e.,  columns listed in Panel 1 of 
Supplementary Figure 1A.
MEMHDX was evaluated using our recently published 
differential HDX-MS dataset generated with the C-terminal 
Repeat-in-toxin  Domain  (RD,  701 residues)  of  the  CyaA 
toxin .  Briefly,  we  used  HDX  to  identify  and  locate 
secondary structural elements in the intrinsically disordered 
Apo-RD  protein,  and  followed  its  transition  to  a  more 
compact and folded state upon calcium binding. In total, 13 
experimental  time  points  were  selected,  and  all  data  was 
collected in triplicate.
3.1. Pre-processing and dataset quality control
A total  of  602  peptic  peptides  of  RD were  identified  by 
ProteinLynX Global Server (Waters Corporation) using the 
default  search  parameters,  of  which  198  remained  after 
filtering by DynamX. Following this, 162 were selected for 
HDX  analysis  and  covered  98.4%  of  the  RD  sequence 
(Supplementary  Figure  2).  Considering  162  peptides,  1 
charge  state,  3  replicates,  14  time  points  (including  the 
unlabeled control) and 2 conditions, we have up to 13,608 
unique  data  points  in  the  complete  test  dataset.  This 
demonstrates  the  complexity  of  datasets  acquired  using 
modern  HDX-MS  pipelines,  the  processing  and 
interpretation of which is extremely challenging and time-
consuming by traditional, manual means.
The current version of MEMHDX can only handle one 
unique  charge  state  per  peptide.  A pre-processing  step  is 
required by the user to select the most appropriate charge 
state for analysis. The quality determination of the dataset is 
directly accomplished by MEMHDX. A Box and Whisker 
plot  displaying  the  agreement  across  replicates  is 
automatically  generated  (Supplementary  Figure  1B1).  For 
each peptide, the calculated deuterium uptake values (Ya,i,r,t) 
are averaged across all time points in each respective state. 
This comparison is possible as each replicate is considered 
as  an  independent  variable. A  scoring  function  (log-
likelihood) is determined per peptide to easily control the 
quality of the fitting. MEMHDX includes a filtering option 
to sort each peptide according to this score and to remove 
those with a low fitting quality from the analysis. 
3.2. Statistical analysis and peptide clustering
A central feature of MEMHDX lies in its ability to classify 
peptides  based  on  their  respective  HDX  behaviors. 
MEMHDX  automatically  summarizes  and  displays  the 
statistical results by means of a “Logit” representation. Two 
adjusted p-values are calculated by the software and define 
the position of each peptide in the “Logit” plot (Figure 2A). 
On the one hand, the magnitude of  ∆D-associated  p-value 
defines  the  magnitude  of  difference  of  deuterium  uptake 
between the two states investigated, while on the other; the 
change  in  dynamics-associated  p-value  describes  the 
timewise  evolution  of  HDX  behavior  between  states. 
Considering  the  magnitude  of  ∆D  only,  the  significance 
increases  (i.e., p-value  decreases)  as  the  peptide  position 
moves  from  right  to  left  on  the  plot,  due  to  the  greater 
magnitude of change observed between states. Similarly, the 
significance of change in dynamics increases as the peptide 
position  moves  from  top  to  bottom.  Deuterium  uptake 
curves for selected peptides are displayed in Figure 2B to 
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illustrate  the  clustering  performed  by  the  software. 
Statistically non-significant peptides are clustered in the top 
Fig. 2. Example of statistical results generated with MEMHDX. 
(A) “Logit” plot obtained with RD. The effect of calcium binding 
on  the  deuterium  uptake  behavior  was  measured  on  162  RD 
peptides. Each dot corresponds to one unique peptide. Peptides are 
classified  and  color-coded  based  on  their  respective  HDX 
behavior: peptides showing dynamic events in both the Apo- and 
Holo-state are colored in gray; peptides only dynamic in the Apo- 
or Holo-state are colored in red and blue; non-dynamic peptides in 
both  states  are  colored  in  green.  The  statistical  significance 
threshold was set to 1%. (B) Deuterium uptake curves for selected 
peptides  in  the  Apo-  (open  circles)  and  Holo-  (filled  squares) 
states. The position of each in the “Logit” plot is also reported.
right-hand  corner  (e.g., peptide  349-365).  Statistically 
significant peptides for the magnitude of ∆D only are found 
at the top of the plot (e.g., peptide 395-401), whereas those 
significant for the change in dynamics  only are plotted on 
the far right (not applicable to this dataset). Those peptides 
which are significant for both states are located in the center 
of the plot. Comparing peptides 395-401, 499-506 and 246-
260 allows us to easily visualize the effect of a change in the 
magnitude of  ∆D- or the change in dynamics-associated  p-
value.  Peptides  395-401  and  499-506  possess  the  same 
magnitude of  ∆D-associated  p-value, but  are separated  by 
their differing change in dynamics-associated  p-value. This 
difference is directly linked to the change of HDX behavior 
observed  in  peptide  499-506  in  the  presence  of  calcium, 
which  is  not  observed  in  the  other  peptide  (Figure  2B). 
Conversely,  peptides  499-506 and 246-260 differ  only by 
their  magnitude  of  ∆D-associated  p-value  because  the 
magnitude  of  difference  between  states  is  less  for  the 
former, than the latter.
MEMHDX enables the user to color code all peptides in 
each state based on their respective HDX behavior (Figure 
2A).  Dynamic  peptides  in  two states  are  colored  in  gray 
(e.g., peptide 587-594), whereas those which are dynamic in 
one or the other state are colored in red or blue [Apo-RD 
(e.g.,  peptide 633-639) in red, and Holo-RD (e.g.,  peptide 
499-506) in blue herein]. Non-dynamic peptides are colored 
in  green  (e.g.,  peptide  395-401).  Results  generated  with 
MEMHDX were compared to those manually obtained for 
RD  .  Excellent  agreement  was  observed  between  the 
automated software and the manual approach. However, the 
speed of analysis was greatly increased by MEMHDX and 
the validation completed in one full  day (10 to 15 sec to 
generate the statistical results by the software, followed by 
several hours of user interpretation), compared to up-to two 
weeks by manual analysis. Visually speaking, the difference 
in deuterium uptake between the two states was too small to 
be considered as significant in the manual analysis of some 
peptides. With the introduction of two independent p-values, 
the sensitivity of MEMHDX over the manual approach is 
enhanced.  This  is  apparent  for  RD  region  1-25,  where 
segment  16-25  was  considered  as  non-significant  in  the 
manual  analysis,  whereas  was  found  to  be  statistically 
relevant by MEMHDX (Figures 3A and B). This illustrates 
the advantages of our automated MEMHDX approach over 
manual means. 
3.3. Global and 3D visualization 
MEMHDX integrates two visualization tools to facilitate the 
interpretation of the HDX results. The “global visualization” 
tool  contains  two  distinct  plots.  The  relative  fractional 
uptake  plot  enables  the  user  to  directly  visualize  and 
compare  the  relative  deuterium  uptake  and  the  exchange 
behavior of each peptide across the entire protein sequence, 
providing  both  spatial  and  temporal  information  (Figure 
3A). Using this representation, the regions of the RD-protein 
containing residual structural  elements in the Apo-state or 
acquiring secondary structures in the Holo-state, are easily 
identified. The second plot displays the difference in relative 
fractional uptake between the two states (Figure 3B). A high 
uptake  difference  indicates  that  the  peptide  incorporates 
more deuterium in state 1 than in state 2 and vice versa. This 
is the case for peptide 203-209 of RD, which incorporates 
more  deuterium  in  the  Apo-state  than  in  the  Holo-state, 
indicative  of  a  calcium-induced  protective  effect  (Figure 
3B).  In  addition, the statistical  results are reported on the 
differential uptake plot. Statistically non-significant peptides 
are  highlighted  in  white,  whereas  those  displaying 
significant p-values in gray.
The second visualization tool allows the mapping of the 
HDX results on the 3D structure of the protein (Figures 3C 
and D). The user can either download a PDB file or enter the 
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Fig. 3.  HDX-MS results visualized by MEMHDX.  (A) Global visualization plots of RD in both the Apo- and Holo-state.  The Relative 
Fractional Uptake values are plotted as a function of peptide position. This representation allows the user to visualize the deuterium uptake  
behavior of each peptide across the entire protein sequence. (B) Fractional Uptake Difference plot showing the variations of deuterium uptake  
between Apo- and Holo-RD. A high uptake difference value corresponds to a large calcium-induced protective effect, while a low value is  
indicative of a weak effect. Significant peptides are highlighted in gray. The statistical significance threshold was set to 1%. (C and D) Mapping  
of the HDX results on the model of RD using the 3D-structural tool of MEMHDX. RD is shown as a cartoon or in a space filling model. Regions 
experiencing deuterium uptake or dynamic changes upon calcium binding are colored in cyan; regions with no change are colored in red.
Protein DataBank identifier of the protein. In this scenario, 
MEMHDX  will  automatically  retrieve  and  display  the 
structure  from  the  protein  databank  archive.  Differential 
exchange  behaviors  will  be  color-coded  to  distinguish 
modified from unmodified regions (Figures 3C and D).
4. CONCLUSIONS
MEMHDX is a statistical tool designed to aid in the analysis 
of  large  HDX-MS  datasets.  The  initial  concept  of  the 
software  was  to  complement  the  HDX-MS  solution 
provided by Waters Corporation, which is to-date, the only 
complete  automated  pipeline  commercially  available.  The 
use  of  two distinct  p-values  in  the  handling of  HDX-MS 
data introduces a novel way to interpret and classify HDX 
results.  This  was  successfully  demonstrated  here  with the 
analysis of the RD protein from the adenylate cyclase toxin. 
In this regard, the validation of the complete RD dataset was 
significantly  expedited,  taking  only  one  day  with 
MEMHDX, compared to up to two weeks when performed 
manually. The current version of the software allows for the 
comparison of two unique conditions using only one unique 
charge state.  As a future perspective,  the software will be 
enhanced  to  allow  for  the  comparison  of  multiple 
conditions, using multiple charge states.
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